Neoplasm. Malignant neoplasms of digestive organ
Conditions
Interventions
Intervention 1: In one group, use chemotherapy to Eloxatin with 130 mg/m2 intravenous for two hours and Epirubicin 50 mg/m2 bolus intravenous and Capecitabine 625 mg/m2 for two days for eight cycles.
Treatment - Drugs
In one group, use chemotherapy to Eloxatin with 130 mg/m2 intravenous for two hours and Epirubicin 50 mg/m2 bolus intravenous and Capecitabine 625 mg/m2 for two days for eight cycles
Two groups use chemotherapy with Docetaxel 40mg/m2 intravenous infusion and Cisplatin 40 mg/m2 intravenous infusion and 5-fluorauacil 400 mg/m2 intravenous infusion for four days for eight cycles
Sponsors
Vice chancellor for research , Jondy Shapor University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion major eligibility criteria : female and male ;18 until 65 years; functional class; critria for histology of adenocarcinoma gastric and Gastroesophageal junction; not finding for family geoghrafic psyicatric state with effect for ejucation; exclusion major eligibility criteria : peripheral nouropathy ; Cerebrovascular disease ;Myocardial infarction ; Pulmonary thrombo emboly ; unstable angina ; uncontrol infection ; pregnancy and lactation ; previce medication for adenocarcinoma; lower limd artritic ; thyapy with phenytoin; known malignancy;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival. Timepoint: To month. Method of measurement: From start chemotherapy to last follow up or recovery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival. Timepoint: To month. Method of measurement: From start chemotherapy to last follow up or partial recovery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPhysician Ahmad Ahmadzadeh
Master of Jondy Shapor University of Medical Sciences
Outcome results
None listed